Sobre a EDCTP
We are in the process of launching our new website. Please come back later to check it out.
A Parceria entre a Europa e os Países em Desenvolvimento para a Realização de Ensaios Clínicos (EDCTP) tem por objectivo acelerar o desenvolvimento de fármacos, vacinas, microbicidas e diagnósticos novos ou melhorados para o VIH/SIDA, a tuberculose e a malária, com particular incidência em ensaios clínicos da fase II e III na África subsaariana.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Latest news
EDCTP Annual Report 2017 - Maintaining momentum
EDCTP published its Annual Report 2017: Maintaining momentum. Since 2014 until the end of 2017, we have awarded 124 grants with an estimated total value of €255.9 million. This includes funding for 32 multicentre clinical trials, accounting for €195.24 million…
EDCTP launches €2.25 M emergency funding initiative in response to Ebola outbreak in the Democratic Republic of Congo
Today, the European & Developing Countries Clinical Trials Partnership (EDCTP) launched an emergency funding initiative ‘Mobilisation of research funds in case of Public Health Emergencies’ to support research activities in response to the Ebola Virus Disease (EVD) outbreak in the…